{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "chem-bla-ics",
  "description": "Chemblaics (pronounced chem-bla-ics) is the science that uses open science and computers to solve problems in chemistry, biochemistry and related fields.",
  "home_page_url": "https://chem-bla-ics.linkedchemistry.info/",
  "feed_url": "https://chem-bla-ics.linkedchemistry.info/2010/12/30/100th-blue-obelisk-2006-paper-citation.json",
  "icon": "https://chem-bla-ics.linkedchemistry.info/assets/images/chem-bla-ics_logo.png",
  "language": "en",
  "authors": [
    {
      "name": "Egon Willighagen",
      "url": "https://orcid.org/0000-0001-7542-0286",
      "_orcid": "0000-0001-7542-0286"
    }
  ],
  "items": [

    {
      "id": "https://doi.org/10.59350/h2ytg-x6f83",
      "url": "https://chem-bla-ics.linkedchemistry.info/2010/12/30/100th-blue-obelisk-2006-paper-citation.html",
      "title": "The 100th Blue Obelisk 2006 paper citation",
      "content_html": "<p>Two and a half months after the CDK milestone, the Blue Obelisk paper also reached\n100 citations. Here the lucky paper is <em>Design, Synthesis, and Preclinical Evaluation\nof New 5,6- (or 6,7-) Disubstituted-2-(fluorophenyl)quinolin-4-one Derivatives\nas Potent Antitumor Agents</em> by Chou et al (doi:<a href=\"http://dx.doi.org/10.1021/jm100780c\">10.1021/jm100780c</a>).\nThe Blue Obelisk paper (doi:<a href=\"http://dx.doi.org/10.1021/ci050400b\">10.1021/ci050400b</a>)\nis cited because the authors used OpenBabel. About half of the 100 citations\nis because <a href=\"http://www.openbabel.org/\">OpenBabel</a> was used, whereas OpenBabel\nis only mentioned as one of the Blue Obelisk-associated unprojects in the Blue\nObelisk paper.</p>\n\n<p>I am not sure how this habit started, but with citation practices, it is unlikely\nto go away. But who am I to complain….</p>",
      "summary": "Two and a half months after the CDK milestone, the Blue Obelisk paper also reached 100 citations. Here the lucky paper is Design, Synthesis, and Preclinical Evaluation of New 5,6- (or 6,7-) Disubstituted-2-(fluorophenyl)quinolin-4-one Derivatives as Potent Antitumor Agents by Chou et al (doi:10.1021/jm100780c). The Blue Obelisk paper (doi:10.1021/ci050400b) is cited because the authors used OpenBabel. About half of the 100 citations is because OpenBabel was used, whereas OpenBabel is only mentioned as one of the Blue Obelisk-associated unprojects in the Blue Obelisk paper.",
      
      "date_published": "2010-12-30T00:20:00+00:00",
      "date_modified": "2010-12-30T00:20:00+00:00",
      "tags": ["blue-obelisk","publishing"],
      
      
      
      
      
      
        "authors": [ { "name": "Egon Willighagen", "url": "https://orcid.org/0000-0001-7542-0286" } ]
      
    }

  ]
}